SB3801 - 104th General Assembly (2025-2026)

PRESCRIPTION LABELING
Last Action

3/11/2026 - Senate: Postponed - Executive
Hearings

Executive Hearing Mar 11 2026 1:00PM Capitol 212 Springfield, IL
Statutes Amended In Order of Appearance

Synopsis As Introduced

Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Actions

DateChamberAction
2/06/2026SenateFiled with Secretary by Sen. Celina Villanueva
2/06/2026SenateFirst Reading
2/06/2026SenateReferred to Assignments
2/11/2026SenateAdded as Co-Sponsor Sen. Rachel Ventura
2/24/2026SenateAssigned to Executive
2/25/2026SenateAdded as Co-Sponsor Sen. Suzy Glowiak Hilton
2/27/2026SenateAdded as Co-Sponsor Sen. Mark L. Walker
3/05/2026SenateAdded as Co-Sponsor Sen. Adriane Johnson
3/11/2026SenatePostponed - Executive